Updated S2k Clinical Practice Guideline on Non-alcoholic Fatty Liver Disease (NAFLD) issued by the German Society of Gastroenterology, Digestive and Metabolic Diseases (DGVS) – April 2022 – AWMF Registration No.: 021

Updated S2k Clinical Practice Guideline on Non-alcoholic Fatty Liver Disease (NAFLD) issued by the German Society of Gastroenterology, Digestive and Metabolic Diseases (DGVS) – April 2022 – AWMF Registration No.: 021–025

Published:2022-09 Issue:09 Volume:60 Page:e733-e801
ISSN:0044-2771
Container-title:Zeitschrift für Gastroenterologie
language:de
Short-container-title:Z Gastroenterol

Author:

Publisher

Georg Thieme Verlag KG

Subject

Gastroenterology

Link

http://www.thieme-connect.de/products/ejournals/pdf/10.1055/a-1880-2388.pdf

Reference659 articles.

1. Mechanisms and disease consequences of nonalcoholic fatty liver disease;R Loomba;Cell,2021

2. Comparison of liver histology between patients with non-alcoholic steatohepatitis and patients with alcoholic steatohepatitis in Japan;Y Morita;Alcohol Clin Exp Res,2005

3. SCLEROSING HYALINE NECROSIS OF THE LIVER IN THE CHRONIC ALCOHOLIC. A RECOGNIZABLE CLINICAL SYNDROME;H A Edmondson;Ann Intern Med,1963

4. Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis;Q Ye;Lancet Gastroenterol Hepatol,2020

5. Prevalence and Profile of Nonalcoholic Fatty Liver Disease in Lean Adults: Systematic Review and Meta-Analysis;S Young;Hepatol Commun,2020

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Obesity and MASLD: Is weight loss the (only) key to treat metabolic liver disease?;Metabolism;2024-08

2. A roadmap for clinical trials in MASH-related compensated cirrhosis;Nature Reviews Gastroenterology & Hepatology;2024-07-17

3. Thy‐1 restricts steatosis and liver fibrosis in steatotic liver disease;Liver International;2024-05-04

4. Adaptation of Clinical Practice Guideline for Assessment of Liver Fibrosis in Patients with Non Alcoholic Fatty Liver Disease in Isfahan Province;International Journal of Preventive Medicine;2024-05

5. Use of non‐invasive diagnostic tools for metabolic dysfunction‐associated steatohepatitis: A qualitative exploration of challenges and barriers;Liver International;2024-04-18